Ultraviolet-C light makes benzalkonium chloride, which is found in many disinfectants, safer to use.
Applying germicidal ultraviolet-C (UVC) light to common disinfectants could make them safer to use and could also help them to better fight COVID-19, according to investigators with the University of Waterloo in Ontario, Canada.
Results from their study were published in the journal Cutaneous and Ocular Toxicology.
“With concerns about the spread of COVID-19, people are utilizing products with BAK as an active ingredient more than ever,” said Manlong Xu, the study’s lead author. “For many industries, there is the demand to improve the efficacy of standard disinfection procedures, while also keeping in mind any potential negative impact on the environment.”
Benzalkonium chloride (BAK), one of the most common active ingredients in many disinfectants that are used in households, food processing plants and hospitals, cannot be used in high concentrations due to its toxicity.
However, in order to protect against harmful viruses and bacteria, high concentrations of BAK are needed, and the residue can harm the environment and people.
For the study, investigators exposed a BAK solution to UVC lamps and then applied the solution to cultured human corneal cells. After 5 minutes, they analyzed the cells for metabolic activity, as well as viability, and found that the BAK solution was neutralized by the UVC and did not harm the cells.
“Our results show that a disinfecting procedure using BAK followed by UVC radiation can minimize the harmful effect of BAK residues on humans and the environment,” David McCanna of Waterloo's Department of Optometry & Vision Science said. “Such a procedure also has a great potential to maximize the disinfection efficacy by utilizing two different antimicrobial mechanisms. As the pandemic continues, our findings are especially important as it provides another method to make our hospitals, food, homes, and the environment safer.”
This story originally appeared in Contagion®.
Herpes and Dentistry: A Silent But Serious Concern
February 21st 2025Herpes infections pose significant risks in dentistry. JoAnn Gurenlian, RDH, PhD, presented prevention, treatment, occupational hazards, and a potential breakthrough in gene therapy that could revolutionize herpes management at the Midwinter Meeting.
Chicago Dental Society Honors Drs Joseph Hagenbruch and Mark Lingen for Excellence in Dentistry
February 21st 2025The Chicago Dental Society honored Dr. Joseph Hagenbruch and Dr. Mark Lingen for their leadership, research, and dedication to advancing dentistry and improving oral health care access.
From Sterilization Tech to Infection Control Advocate: Sherrie Busby’s Inspiring Dental Journey
February 20th 2025Sherrie Busby, EDDA, CDSO, CDIPC, shares her journey from dental assisting to infection control advocacy, highlighting her passion for education, her role at Heartland Dental, and her exciting transition to a new chapter.
Innovation and Infection Control: Highlights From W&H at Chicago Dental Midwinter Society Meeting
February 19th 2025Doris Schneider, senior marketing manager for North America for W&H North America, shares insights into the 160th Chicago Dental Society Midwinter Meeting, showcasing the Lexa Mini rapid sterilizer and Sanaa Power handpiece, designed for efficient sterilization and effortless dental procedures.